“https://doi.org/10.1177/20503245231198472From prohibited to prescribed: The rescheduling of MDMA and psilocybin in Australia (Ritchie et al.)Sep 7, 2023Sep 7, 2023
Review of studies on the use of microdosing with hallucinogens that combine psychotherapeutic…Published: Sep 1, 2023 SciELO PreprintsSep 2, 2023Sep 2, 2023
(Provisionally Accepted) The Montreal Model: An Integrative Biomedical-Psychedelic Approach to…Accepted: Aug 30, 2023 Frontiers in PsychiatrySep 2, 2023Sep 2, 2023
The changing outlook of psychedelic drugs: The importance of risk assessment and occupational…Published: Aug 30, 2023 Journal of Applied ToxicologyAug 30, 2023Aug 30, 2023
Development and Validation of a Sensitive LC-MS/MS Method to Quantify Psilocin in Authentic Oral…Published: Aug 29, 2023 Journal of Analytical ToxicologyAug 29, 2023Aug 29, 2023
(PREPRINT) Psychedelics and Artificial Intelligence: Integrating AI-Powered Analysis in…Available Online: Aug 28, 2023 PsyArXivAug 29, 2023Aug 29, 2023
Qualitative Study About Psychedelics Using in Psychiatric Disorders (PSYCHEQUALI)First Posted: 2023–08–28 Sponsor: University Hospital, Toulouse Not Yet RecruitingAug 28, 2023Aug 28, 2023
(Provisionally Accepted) Lifeboat ethics, risk, and therapeutic opportunity: An appeal for…Accepted: Aug 28, 2023 Frontiers in PsychiatryAug 28, 2023Aug 28, 2023
(Provisionally Accepted) Back from the rabbit hole.Accepted: Aug 25, 2023 Frontiers in PsychologyAug 26, 2023Aug 26, 2023
Race and ethnicity moderate the associations between lifetime psilocybin use and crime arrests…Published: Aug 24, 2023 Frontiers in PsychiatryAug 24, 2023Aug 24, 2023
